In our opinion, the activation of these inflammatory pathways (macrophages and IL-6) in COVID-19 infections and the evidence from other studies highlighting Interleukins and cytokines as markers of preterm delivery in normal pregnancies [28–31] are a case for further evaluation of this association in COVID-19-positive pregnant women. The gene discussed is IL6; the disease is COVID-19.